Death Clinical Trial
— 3WPOfficial title:
Compassionate End of Life Care in the ICU: Evaluating the Value, Transferability, Affordability, and Sustainability and Value of the 3 Wishes Project
Verified date | October 2019 |
Source | McMaster University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The 3 Wishes Project (3WP) was created to promote the connections between patients, family
members, and clinicians that are foundational to empathic end-of-life care. It provides a
scaffold for discussions about preferences and values at the end of life and leads to acts of
compassion that arise from soliciting and implementing wishes that honour the dying patient.
In a single center, investigators previously reported how the 3 Wishes Project forges
interpersonal connections among patients, family members and clinicians, eases family grief,
and offers experiential end of life education for clinicians-in-training.
The objective of this study was to evaluate whether the 3 Wishes Project could enhance
compassionate care for dying patients and their families when implemented as a multicenter
program. Given the importance of empowering frontline staff to adapt the 3WP to their own
practice patterns, investigators did not protocolize this approach to personalizing
end-of-life care. Investigators conceptualized this study as a formative evaluation of 3WP to
examine its 1) Value: as experienced by family members, frontline clinicians, ICU managers
and hospital administrators; 2) Transferability: successful implementation beyond the
original ICU by a different mix of clinicians; 3) Affordability: cost of wishes being less
than $50/patient; 4) Sustainability: project continuation beyond the first year of
evaluation.
Status | Completed |
Enrollment | 730 |
Est. completion date | April 12, 2019 |
Est. primary completion date | December 31, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Patient Inclusion Criteria: 1. Patient is >18 years of age (a subgroup analysis will be conducted on those >65 years of age); 2. Patient has a >95% of dying during the ICU stay as judged by the ICU attending physician; or 3. a decision has been made to withdraw or withhold advanced life support in anticipation of death. Patient/Family Exclusion Criteria: 1. Prohibitive communication challenges (e.g., serious psychological or psychiatric illness in the patient and/or family, inability of patient and/or family to communicate reasonably well in English or other language for which an interpreter exists - professional staff or otherwise); 2. Prohibitive logistics (e.g., patient admitted to the ICU for <24 hours, or anticipated to die within 24 hours of screening) 3. Patient or family declines. (Note that a patient who has "no family" (even very broadly defined as friends and neighbours, or community members and case workers for homeless persons) would not be excluded from the wish elicitation and implementation component of the project. |
Country | Name | City | State |
---|---|---|---|
Canada | St. Joseph's Healthcare | Hamilton | Ontario |
Lead Sponsor | Collaborator |
---|---|
McMaster University | The Greenwall Foundation |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Perceptions and beliefs about value of the program | Given the nascent knowledge of experiences and perceptions of value, it is important that investigators first understand which program elements family members and clinicians appreciate, and what their experiences of these elements are. In future research, investigators will then measure achievement in those domains. Accordingly, in this study investigators will solicit open-ended, qualitative perceptions of value of the program from family members, clinicians, and ICU managers and hospital administrators. This information will be analyzed inductively to generate domains of value which may be measured in future research. Inductive analysis involves generation of categories and domains directly from the data, without pre-conceived notions of what these categories or domains might be. By generating understanding of the types of value family members, clinicians and managers see in this program, investigators will be able to devise ways to measure this value in future research. | Through study completion, an average of 1 year. | |
Primary | Transferability as indicated by successful establishment in 3 new ICU settings | Successful implementation beyond the original ICU by a different mix of clinicians. | Through study completion, an average of 1 year. | |
Primary | Affordability: cost of wishes being less than $50/patient. | The $50/patient figure quoted does not refer to patient compensation. Instead, it refers to the cost of running the intervention for each enrolled patient. Given the individually-adapted nature of this intervention, the costs will vary per participant. Affordability of the program to the ICU running the program is an essential part of information collected in this program evaluation. Affordability will be informed by mean cost per wish and per patient at each center and overall. Also, investigators will perform a cost description of the project including both direct and indirect costs. |
Through study completion, an average of 1 year | |
Primary | Sustainability of the intervention after the research study has been completed. | Sustainability will be affirmed if the project remains operational in each ICU in July 2019. | 6 months after study completion |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03646955 -
Partial Breast Versus no Irradiation for Women With Early Breast Cancer
|
N/A | |
Recruiting |
NCT02552706 -
The Efficacy and Mechanisms of Oral Probiotics in Preventing Necrotizing Enterocolitis
|
N/A | |
Completed |
NCT01569178 -
BAMI. The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells(BM-MNC) on All Cause Mortality in Acute Myocardial Infarction
|
Phase 3 | |
Recruiting |
NCT01193751 -
Apgar-Score in Asphyxiated Infants Under Resuscitation
|
N/A | |
Active, not recruiting |
NCT01597453 -
NOR-SYS: The Norwegian Stroke in the Young Study
|
N/A | |
Completed |
NCT00399503 -
Assessment of Noninvasive Methods to Identify Patients at Risk of Serious Arrhythmias After a Heart Attack
|
N/A | |
Completed |
NCT05128799 -
Effect of the 3 Wishes Program on Bereaved Families' End-of-Life Care Perceptions
|
||
Completed |
NCT00340015 -
A Prospective Study of Diet and Cancer in Members of the American Association of Retired Persons
|
||
Active, not recruiting |
NCT01618123 -
Association of Endothelial Function and Clinical Outcomes in Subjects Admitted to Chest Pain Unit
|
||
Completed |
NCT01008241 -
South Florida Residents Knowledge and Opinions on End-of-Life Issues
|
||
Completed |
NCT00225394 -
Long Term Use of Valganciclovir for Prophylaxis of CMV Disease in Kidney and Pancreas Transplant Patients
|
Phase 4 | |
Terminated |
NCT05518474 -
Self-proning and Repositioning in COVID-19 Outpatients at Risk of Complicated Illness
|
N/A | |
Completed |
NCT02533128 -
Biomarkers, Blood Pressure, BIS: Risk Stratification/Management of Patients at Cardiac Risk in Major Noncardiac Surgery
|
N/A | |
Recruiting |
NCT05199025 -
Biomarkers in Perioperative Management
|
||
Not yet recruiting |
NCT06371677 -
Polish Nationwide Register of Hospitalized Patients in Cardiac Intensive Care Units
|
||
Completed |
NCT04709120 -
Analysis of Health Status of Сomorbid Adult COVID-19 Patients Hospitalised in Second Wave of SARS-CoV-2 Infection
|
||
Enrolling by invitation |
NCT05374291 -
The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKD
|
Phase 3 | |
Recruiting |
NCT01792739 -
Lactobacillus Preparation on the Incidence of Diarrhea
|
Phase 4 | |
Completed |
NCT00753428 -
Community-based Evaluation of a Pilot PMTCT Project in Kafue District
|
||
Completed |
NCT00495690 -
Impact of Daily Zinc Supplementation to Infants Born With Low Birth Weight on Death and Severe Disease
|
Phase 3 |